Endocrinology and Diabetes Mellitus
Clinical research is centered on type 2 diabetes mellitus, with attention to glycaemic management in patients requiring ongoing insulin therapy.
- Insulin glargine treatment
- Glycaemic control
- Continuous glucose monitoring
The sponsor’s activity reflects interest in therapies used to maintain blood glucose stability in diabetes care.
Renal Impairment in Metabolic Disease
Research also addresses renal impairment in people living with type 2 diabetes, focusing on treatment needs when kidney function is reduced.
- Diabetic kidney disease
- Renal failure
- Metabolic comorbidity
This area highlights therapeutic interest in managing diabetes alongside kidney dysfunction.
Insulin Therapy Optimization
The funded research landscape includes evaluation of insulin formulation changes for patients already treated with basal insulin.
- Basal insulin
- Insulin switching
- Long-acting insulin analogues
These interests are aligned with practical treatment selection in diabetes management.
Glucose Monitoring and Treatment Safety
Another focus is the use of continuous glucose monitoring to assess treatment performance and safety in routine clinical care.
- Hypoglycaemia
- Glycaemic variability
- Treatment safety
This supports clinical interest in monitoring glucose patterns during insulin therapy in patients with complex comorbidity.
